- Home
- AENT vs SGMO Comparison
AENT vs SGMO Comparison
Compare AENT & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AENT
- SGMO
- Stock Information
- Founded
- AENT 1990
- SGMO 1995
- Country
- AENT United States
- SGMO United States
- Employees
- AENT N/A
- SGMO N/A
- Industry
- AENT Durable Goods
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AENT Consumer Discretionary
- SGMO Health Care
- Exchange
- AENT Nasdaq
- SGMO Nasdaq
- Market Cap
- AENT 161.5M
- SGMO 180.5M
- IPO Year
- AENT N/A
- SGMO 2000
- Fundamental
- Price
- AENT $3.75
- SGMO $0.91
- Analyst Decision
- AENT
- SGMO Buy
- Analyst Count
- AENT 0
- SGMO 4
- Target Price
- AENT N/A
- SGMO $2.67
- AVG Volume (30 Days)
- AENT 75.0K
- SGMO 2.3M
- Earning Date
- AENT 12-08-2024
- SGMO 10-30-2024
- Dividend Yield
- AENT N/A
- SGMO N/A
- EPS Growth
- AENT N/A
- SGMO N/A
- EPS
- AENT 0.09
- SGMO N/A
- Revenue
- AENT $1,100,483,000.00
- SGMO $12,277,000.00
- Revenue This Year
- AENT $4.77
- SGMO N/A
- Revenue Next Year
- AENT N/A
- SGMO $52.02
- P/E Ratio
- AENT $35.22
- SGMO N/A
- Revenue Growth
- AENT N/A
- SGMO N/A
- 52 Week Low
- AENT $0.65
- SGMO $0.29
- 52 Week High
- AENT $3.99
- SGMO $1.48
- Technical
- Relative Strength Index (RSI)
- AENT 71.93
- SGMO 55.27
- Support Level
- AENT $2.45
- SGMO $0.77
- Resistance Level
- AENT $2.95
- SGMO $1.07
- Average True Range (ATR)
- AENT 0.33
- SGMO 0.07
- MACD
- AENT 0.07
- SGMO 0.01
- Stochastic Oscillator
- AENT 100.00
- SGMO 52.42
About AENT Alliance Entertainment Holding Corporation
Alliance Entertainment Holding Corp is a top-tier distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.